InChI=1S/C44H80NO8P/c1- 6- 8- 10- 12- 14- 16- 18- 20- 21- 22- 23- 25- 27- 29- 31- 33- 35- 37- 44(47) 53- 42(41- 52- 54(48,49) 51- 39- 38- 45(3,4) 5) 40- 50- 43(46) 36- 34- 32- 30- 28- 26- 24- 19- 17- 15- 13- 11- 9- 7- 2/h14,16,20- 21,23,25,29,31,42H,6- 13,15,17- 19,22,24,26- 28,30,32- 41H2,1- 5H3/b16- 14+,21- 20+,25- 23+,31- 29+/t42- /m1/s1 |
IIZPXYDJLKNOIY-LBKRVYFZSA-N |
CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C\C\C=C\C\C=C\C\C=C\CCCCC |
|
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
(via phosphatidylcholine 36:4 )
|
|
View more via ChEBI Ontology
Outgoing
|
1- hexadecanoyl- 2- (5E,8E,11E,14E- eicosatetraenoyl)- sn- glycero- 3- phosphocholine
(CHEBI:84794)
has role
mouse metabolite
(CHEBI:75771)
1- hexadecanoyl- 2- (5E,8E,11E,14E- eicosatetraenoyl)- sn- glycero- 3- phosphocholine
(CHEBI:84794)
is a
phosphatidylcholine 36:4
(CHEBI:64520)
|
|
(2R)- 3- (hexadecanoyloxy)- 2- [(5E,8E,11E,14E)- icosa- 5,8,11,14- tetraenoyloxy]propyl 2- (trimethylammonio)ethyl phosphate
|
PC(16:0/20:4(5E,8E,11E,14E))
|
LIPID MAPS
|
PC(16:0/20:4)
|
LIPID MAPS
|
|